Publications by authors named "Katarzyna Szlezinger"
Article Synopsis
- Breast cancer (BC) is the most prevalent cancer type in women, and this study evaluated eligibility criteria in recent clinical trials that may hinder older patients and those with other health issues from participating.
- The analysis covered 522 systemic anticancer treatment trials conducted between 2020 and 2022, revealing that a significant number (94%) had strict criteria like upper age limits and comorbidity exclusions.
- The findings indicated a notable increase in exclusion criteria for older patients and those with poor performance compared to trials from 2010-2012, suggesting a need for modifications in trial design to be more inclusive.
